Investigating how immune interactions affect brain metastasis in cancer patients
Exploring the Function of MHC-II/Lag3 Axis in Brain Metastasis to Develop Novel Therapeutic Strategies
This study is looking at how brain cancer cells interact with the brain's immune cells to find new ways to help people with brain metastasis, which is when cancer spreads to the brain.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tx Md Anderson Can Ctr NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-10897154 on NIH RePORTER |
What this research studies
This research focuses on understanding the unique interactions between brain metastasis (BM) tumor cells and the brain's environment, which is crucial for developing new treatments. The study explores how microglia, the brain's immune cells, interact with BM cancer cells through specific proteins, potentially inhibiting tumor growth. By examining the role of MHC-II molecules and their regulation in cancer cells, the research aims to identify novel therapeutic strategies that could improve outcomes for patients with brain metastasis.
Who could benefit from this research
Good fit: Ideal candidates for this research are cancer patients who have developed brain metastasis, particularly those with symptomatic conditions.
Not a fit: Patients without brain metastasis or those with primary brain tumors may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapies that significantly improve survival rates and quality of life for patients with brain metastasis.
How similar studies have performed: Previous research has shown promise in targeting immune interactions in cancer treatment, suggesting that this approach could yield significant advancements.
Where this research is happening
Houston, United States
- University of Tx Md Anderson Can Ctr — Houston, United States (Active)
Researchers
- Principal investigator: Yu, Dihua — University of Tx Md Anderson Can Ctr
- Study coordinator: Yu, Dihua
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.